CASP9 and colorectal carcinoma: Treatment of CRC cells with FSTL1 AS increased expression of active forms of caspase-9, caspase 3 and its direct substrate, poly ADP-ribose polymerase (PARP) (Figure 4B and Supplementary Figure 2B).